Current Group Members

MIR Research Group
Liam Goldman ‘20

Liam is a Neuroscience major and has been working with Dr. Stoddard’s since his first semester at Rhodes College fall 2016.  Liam has worked on the development of novel therapeutics for autoimmune diseases utilizing both computational and experimental techniques such as in silico protein engineering, protein-protein docking, protein expression and purification, and ELISA assays.  Currently Liam is focusing on synthesis and biological testing of novel therapeutics for Huntington’s disease. Liam's work lead to the publication Design and Synthesis of Diazine-based Panobinostat Analogues for HDAC8 Inhibition in the Beilstein Journal of Organic Chemistry. After Rhodes Liam will be attending The Medical College of Georgia!

Maggie Palopoli ‘20

Maggie is a Biochemistry and Molecular Biology major who has worked in Dr. Stoddard’s lab since fall 2017.  Maggie’s work has focused on developing novel therapeutic proteins for primary membranous nephropathy, and characterizing one of the proteins targeted in this disorder. Maggie's work involves computational techniques such as in silico protein engineering and protein-protein docking. Part of Maggie’s work on the thrombospondin type-1 containing domain 7A (THSD7A) was published in PROTEINS: Structure Function and Bioinformatics December in 2018.  Maggie plans to attend medical school after Rhodes.

Itthipoaln Rasasack ‘20

Itthipoaln is a Biochemistry and Molecular Biology major who has worked in Dr. Stoddard’s lab since spring 2017. Itthipoaln’s work has focused on developing novel therapeutic proteins for the autoimmune disorder systemic lupus erythematosus. Itthipoaln's work utilizes both computational and experimental techniques such as in silico protein engineering, protein-protein docking, epitope prediction, homology modeling, protein expression and purification. After graduating from Rhodes Itthipoaln plans to attend medical school.

Omar Stocks ‘20

Omar is a Biology major who has worked in Dr. Stoddard’s lab since spring 2017.  Omar’s work has focused on developing novel therapeutic proteins for primary membranous nephropathy an autoimmune kidney disease. Omar's project focuses on developing strategies for patients who express antibodies to the phospholipase A2 receptor. In addition to development of therapeutic interventions, Omar has focused on development of 3D models of the PLA2R protein as a tool for scientist and the prediction of epitope sites on the PLA2R protein. Omar's work utilizes both computational and experimental techniques such as in silico protein engineering, protein-protein docking, epitope prediction, homology modeling, protein expression and purification. Omar plans to attend medical school after graduation from Rhodes.

Aryan Galani ‘21

Aryan is a Biochemistry and Molecular Biology major who has worked in Dr. Stoddard’s lab since summer 2018.  Aryan’s work focuses on developing new approaches to autoimmune disorders. Aryan's work focuses on development of therapeutic interventions for patients who express antibodies to the thrombospondin type-1 containing domain 7A protein. Aryan's work involves both computational techniques such as protein-protein docking, in silico protein engineering and experimental techniques such an protein expression and purification.  Aryan plans to attend medical school after Rhodes College.

Brandon James ‘21

Brandon is a Chemistry major who has worked in Dr. Stoddard’s lab since spring 2019.  Brandon’s work focuses on design, synthesis and evaluation of novel therapeutics for the cancer disorder glioma which is sensitive to histone deactylase 4 (HDAC4) expression level.  Brandon's work involves both computational techniques such as molecular docking and in silico drug design in addition to synthesis of cyclopropane hydroxamate acid derivatives developed in this lab to target HDAC4 as a potential treatment for glioma.  Brandon plans to attend dental school after Rhodes College.

Kaylah Whalum ‘21

Kaylah is a Chemistry major who has worked in Dr. Stoddard’s lab since spring 2019.  Kaylah’s work focuses on developing novel therapeutic proteins for primary membranous nephropathy.  Kaylah's focuses on design on therapeutics for patients who express antibodies against the thrombospondin type-1 containing domain 7A. Her work involves both computational in silico protein engineering, protein-protein docking, and experimental biochemical techniques to express, purify, and characterize the engineered proteins. After Rhodes Kaylah plans to go to dental school.

Kathryn Edwards '21

Kathryn is a chemistry major who joined Dr. Stoddard's MIR research Lab summer 2019.  Kathryn's work focuses on synthesis and biological investigation of novel HDAC4 inhibitors.  Her project is a collaborative project between Dr. Stoddard's lab and Dr. Bea's lab.  Kathryn's work involves the synthesis of cyclopropane hydroxamate acid derivatives being developed in this lab for glioma therapeutics.  After graduation from Rhodes Kathryn plans to pursue a degree in medicine. 

Keerthana Kasetty '21

Keerthana is a Biology major who joined Dr. Stoddard's Lab in Fall 2019.  Keerthana's work focuses on developing novel therapeutics for idiopathic membranous nephropathy.  She focuses on therpeutics designed for patients who have antibodies targeting the thrombospondin type-1 containing domain 7A protein.  Keerthana's work utilizes both computational and experimental techniques such as protein-protein docking, in silico design, protein expression and purification. After Rhodes Keerthana plans to go to medical school.

Kennedi Fitts '21

Kennedi joined Dr. Stoddard's research lab fall 2019.  Kennedi is a Chemistry major and her research focuses on development of selective inhibitors for histone deacetylases (HDAC), with an emphasis on HDAC11.  After Rhodes Kennedi plans to attend medical school.  Kennedi's work involves molecular docking simulations, in silico design of novel drug compounds, and optimization of molecular features leading to enhanced binding to protein receptors of interest.